30 completed, 9 unknown, 5 terminated, 3 recruiting. 19 Phase 2, 14 Phase 4, 8 Not applicable, 5 Phase 1, 5 Phase 3.
Follow this drug Literature Review of Dipyridamole trials Research Report on Dipyridamole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dipyridamole for Early-Onset Preeclampsia: A Pilot Study of Feasibility, Pharmacokinetics, and Biological Effects Dipyridamole 75 MG - Preeclampsia (PE), Hypertension ,Pregnancy | Phase 1 / Phase 2 | Not yet recruiting | Hadassah Medical Organization | 15 | 2026-09-01 | 2026-07-31 |
| A Self-Controlled Study on the Treatment of Restless Legs Syndrome in Uremia With Dipyridamole Dipyridamole 50mg tid - Restless Leg Syndrome Due to Uraemia | Phase 2 / Phase 3 | Recruiting | Yunfeng Xia | 80 | 2025-09-20 | 2026-04-22 |
| Pioneering Advancements in Cardiocerebrovascular Interactions in the Asia pacFIC - Patent Foramen Ovale Study PFO closure using approved PFO closure devices, Surgical PFO closure, Medical management - Ischemic Stroke, Patent Foramen Ovale | Not yet recruiting | National University Hospital, Singapore | 1000 | 2025-07-01 | 2025-05-21 | |
| Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients Dipyridamole 75 MG - Hypophosphatemia, Kidney Transplantation | Phase 2 | Recruiting | Stanford University | 90 | 2025-05-15 | 2026-06-11 |
| Antiplatelet Therapy for AIS Patients With Thrombocytopenia aspirin, clopidogrel, cilostazol, and dipyridamole - Acute Ischemic Stroke, Thrombocytopenia | Not applicable | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 1200 | 2023-09-15 | 2023-10-18 |
| Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection Apixaban 2.5 MG, Dipyridamole 25Mg Tab, subcutaneous Low Molecular Weight Heparin - Cirrhosis, Splenectomy | Not applicable | Completed | Northern Jiangsu People's Hospital | 40 | 2022-04-01 | 2023-12-21 |
| Brequinar Combined With Dipyridamole in Patients With Mild to Moderate COVID-19 Brequinar Sodium, Dipyridamole 75 MG, Placebo - COVID-19 | Phase 2 | Terminated | Clear Creek Bio, Inc. | 26 | 2022-02-01 | 2023-11-07 |
| BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome. Adenosine, Dipyridamole 200 mg, Apixaban 5 mg Oral Tablet - Takotsubo Syndrome | Phase 4 | Recruiting | Vastra Gotaland Region | 1000 | 2020-12-14 | 2024-12-02 |
| Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT） Apixaban, Warfarin, Aspirin - Cirrhosis, Splenectomy; Status | Phase 4 | Completed | Northern Jiangsu People's Hospital | 120 | 2020-11-22 | 2025-03-21 |
| Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19 Placebo, Dipyridamole Tablets - COVID-19 Pneumonia, Vascular Complications | Phase 2 | Terminated | UConn Health | 41 | 2020-05-03 | 2023-04-21 |
| Antiplatelet Therapy in Chronic Urticaria Desloratadine plus cilostazol and dipyridamole, Desloratadine - Chronic Urticaria | Phase 2 | Unknown | Chulalongkorn University | 12 | 2018-06-01 | 2024-02-21 |
| Assessment of the Efficacy of Ocular Dipyridamole in the Treatment of Dry Eye Symptomology in Subjects With Pterygium Dipyridamole, Placebo - Dry Eye Syndromes, Pterygium | Phase 2 | Unknown | Ariel University | 40 | 2016-07-01 | 2016-05-25 |
| Registry of IgA Nephropathy in Chinese Children Corticosteroid, Cyclophosphamide, Mycophenolate mofetil - IgA Nephropathy, Proteinuria in Nephrotic Range | Unknown | Peking University First Hospital | 1200 | 2016-01-01 | 2023-12-06 | |
| Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection Warfarin, Dipyridamole, Aspirin - Cirrhosis, Hypertension | Phase 4 | Completed | Yangzhou University | 124 | 2014-09-01 | 2019-03-29 |
| Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation Apixaban, Aspirin, Carbasalate calcium - Cerebral Hemorrhage, Atrial Fibrillation | Phase 2 | Completed | UMC Utrecht | 101 | 2014-09-01 | 2021-04-14 |
| Study on Children Henoch-Schönlein Purpura Nephritis With TCM Multistep Treatment Glycosides Of Tripterygium Wilfordii Hook(GTW), Sulfotanshinone Sodium Injection, Chinese herbs based on syndrome differentiation - Henoch-Schönlein Purpura Nephritis | Phase 1 / Phase 2 | Unknown | Henan University of Traditional Chinese Medicine | 500 | 2014-09-01 | 2018-07-19 |
| Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy Warfarin, Dipyridamole, Aspirin - Cirrhosis, Hypertension | Phase 4 | Unknown | Yangzhou University | 60 | 2014-09-01 | 2019-01-02 |
| Dipyridamole for Immune Activation in HIV Dipyridamole, Placebo, then Dipyridamole - HIV Infection | Phase 1 / Phase 2 | Completed | Sharon Riddler | 40 | 2014-07-01 | 2019-04-11 |
| Metformin-Dipyridamole Interaction Trial Metformin, dipyridamole, Metformin - Diabetes | Phase 4 | Completed | Radboud University Medical Center | 18 | 2012-04-01 | 2013-04-29 |
| Phase II Study for the Diagnosis and Functional Assessment of CAD Using Transthoracic-Echodoppler adenosine + dipyridamole - Ischemic Heart Disease | Phase 2 | Unknown | Adenobio N.V | 75 | 2011-06-01 | 2012-09-07 |
Showing 20 of 50. Sign in to see all of them.
Cardiovascular Diseases (6) · Myocardial Ischemia (5) · Fibrosis (4) · Venous Thrombosis (4) · Arthritis, Rheumatoid (3) · Atherosclerosis (3) · Coronary Disease (3) · Heart Diseases (3) · Hypertension (3) · Reperfusion Injury (3) · Stroke (3) · Carotid Stenosis (2) · Coronary Artery Disease (2) · Foramen Ovale, Patent (2) · Hypertension, Portal (2)
Radboud University Medical Center (7) · Zalicus (4) · Boehringer Ingelheim (2) · National Heart, Lung, and Blood Institute (NHLBI) (2) · Northern Jiangsu People's Hospital (2) · UConn Health (2) · UMC Utrecht (2) · Yangzhou University (2) · Adenobio N.V (1) · Ariel University (1) · Children's Hospital Medical Center, Cincinnati (1) · Chulalongkorn University (1) · Clear Creek Bio, Inc. (1) · Emory University (1) · Hadassah Medical Organization (1)
United States (15) · Netherlands (9) · China (8) · Canada (3) · Denmark (2) · Israel (2) · Argentina (1) · Brazil (1) · Estonia (1) · France (1) · Hungary (1) · India (1) · Italy (1) · Lithuania (1) · Mexico (1)
Margaret Lee, PhD (4) · Ping Chen, MD (3) · Dou-Sheng Bai, MD (2) · Gerard Rongen, MD PhD (2) · Guo-Qing Jiang, MS (2) · A. Algra, Professor (1) · Bao-Huan Zhou, MS (1) · Bart P Ramakers, MD (1) · Bruce Liang, MD (1) · Bruce T Liang, MD (1) · Catharina JM Klijn, MD PhD (1) · Catherine Meyers, M.D. (1) · Dou-Sheng Bai Bai, MD (1) · Elmir Omerovic, MD PhD (1) · Emile R Mohler, MD (1)
PMID 10332540, PMID 10849191, PMID 10851208, PMID 11927799, PMID 12119802, PMID 12923400, PMID 15738343, PMID 16391172, PMID 16533484, PMID 16714187, PMID 17239798, PMID 17470859, PMID 18426998, PMID 18477783, PMID 18681754, PMID 19047577, PMID 19458364, PMID 19738158, PMID 21330625, PMID 22129171, PMID 22801444, PMID 23266540, PMID 25773594, PMID 28902580, PMID 29090661, PMID 31464626, PMID 31820157, PMID 34022170, PMID 34298589, PMID 34455822, PMID 34518951, PMID 34687635, PMID 35224730, PMID 36435233, PMID 36700520, PMID 9342776, PMID 9369256, PMID 9890307
2009 (1), 2014 (1), R01HL031025 (1), R37HL041619 (1), U01AI110410 (1), U01DK058982 (1), U10CA032102 (1), U54HL070871 (1)